Business
Starpharma commences phase 1/2 DEP irinotecan trial
Starpharma commences phase 1/2 DEP irinotecan trial
About this update from Starpharma Holdings Limited
[{"type":"text","content":"Starpharma Holdings Ltd has released a press release. View Attachment","length":234,"tagName":"div"}]